Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Accupack Midwest, Inc.
WARNING LETTER
•Accupack Midwest, Inc.•February 27, 2024

Accupack Midwest, Inc. – FDA Warning Letter, Feb 27, 2024

Record Details

The FDA inspected Accupack Midwest, Inc.'s drug manufacturing facility in Cincinnati, Ohio, from February 22-27, 2024, identifying significant Current Good Manufacturing Practice (CGMP) violations. The firm contract manufactures OTC drug products, including sunscreens, anti-itch creams, and analgesics.

Violations include failure to establish adequate laboratory controls (21 CFR 211.160(b)), specifically lacking appropriate specifications and testing for component water, such as limits for objectionable microorganisms, total organic carbon, or conductivity to meet Purified Water USP monograph specifications. The firm also failed to adequately monitor its water system, with noted failures in (b)(4) testing and retesting without proper investigation (21 CFR 211.192).

Additionally, the firm failed to establish written procedures for production and process control (21 CFR 211.100(a)), as processes for OTC drug products were not validated, equipment qualification was not performed on manufacturing equipment, and the water system lacked appropriate qualification.

The FDA reviewed the firm's March 18, 2024, response to Form FDA 483 and held a teleconference on June 17, 2024. Accupack Midwest has committed to temporarily ceasing drug production. The FDA recommends engaging a qualified CGMP consultant to evaluate operations, perform a comprehensive six-system audit, and

Company
Accupack Midwest, Inc.
Inspection date
February 27, 2024
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations III
Person
  • Rebecca E. Dowd (Director of Investigations Branch)
View Company Profile

ID · 3f22f0c7-9e09-4b25-ac74-a5fed9b04354

Violation Codes8
21 CFR 21021 CFR 21121 CFR 211.160(b)21 CFR 211.19221 CFR 211.100(a)21 CFR 211.34FD&C Act 501(a)(2)(B)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Accupack Midwest, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.